Ardent Health (ARDT) EBIT (2023 - 2026)

Ardent Health's EBIT history runs 4 years deep, the most recent figure standing at -$194.0 million for Q1 2026.

• In Q1 2026, EBIT fell 5.04% year-over-year to -$194.0 million; the TTM figure through Mar 2026 stood at -$728.7 million (down 83.72% YoY), while the FY2025 annual figure was -$796.6 million, down 498.19% from the prior year.
• EBIT for Q1 2026 stood at -$194.0 million, down from -$185.2 million in the prior quarter.
• The five-year high for EBIT was $25.9 million in Q4 2024, with the low at -$642.6 million in Q4 2023.
• The 4-year median for EBIT is -$180.9 million (2024), against an average of -$173.1 million.
• The sharpest annual moves came in 2024 and 2025: EBIT soared 104.03% in 2024, then tumbled 815.52% in 2025.
• Ardent Health's EBIT stood at -$642.6 million in 2023, then surged by 104.03% to $25.9 million in 2024, then sank by 815.52% to -$185.2 million in 2025, then fell by 4.75% to -$194.0 million in 2026.
• Business Quant data shows ARDT's EBIT at -$194.0 million in Q1 2026, -$185.2 million in Q4 2025, and -$200.9 million in Q3 2025.